What does Nanjing Well Pharmaceutical Group Co.,Ltd. do?

Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 603351.SS's market cap?

Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) has a market capitalization of approximately $3.55 billion, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does 603351.SS pay a dividend?

Yes — Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) pays a dividend annually, with a trailing-twelve-month yield of 2.29%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

603351.SS

Nanjing Well Pharmaceutical Group Co.,Ltd.

SHH·Drug Manufacturers, Specialty & Generic · Healthcare

¥26.23¥0.37−1.39%

Market cap¥3.55B·Market closed·Aug 27 7:00 AM UTC

Price Chart

¥26.23−¥0.37 (−1.39%)today

+37.11%CAGR +6.52%

Select date range

FromTo

Jan 30, 2019Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)2.29%

Annual Dividend (FWD)¥0.60

Dividend Growth (5Y)+14.9%

Dividend Safety—

Payout Ratio57.9%

FCF Payout Ratio39.1%

Most Recent Dividend¥0.600

Ex-Dividend DateJun 5

Payment DateJun 5

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)+9.6%

EPS Growth (3Y)+20.6%

EPS Growth (5Y)+8.4%

Next Earnings DateApr 21

Last Report DateJun 30

Reported vs Estimate¥0.27

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥1.40B

Net Income¥154.99M

Net Margin11.1%

Operating Cash Flow¥258.02M

Capital Expenditures¥50.16M

Free Cash Flow¥207.86M

Return on Equity8.7%

Return on Invested Capital1.7%

Net Debt¥204.24M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 603351.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 603351.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 603351.SS and 80,000+ other tickers.

About Nanjing Well Pharmaceutical Group Co.,Ltd.

Nanjing Well Pharmaceutical Group Co., Ltd., founded in 2000 and headquartered in Nanjing, China, is primarily engaged in the research, development, manufacturing, and distribution of pharmaceutical excipients within the Chinese market. These essential auxiliary materials are utilized in both injectable and non-injectable drug formulations. Beyond its pharmaceutical focus, the company also supplies an extensive range of synthetic base oils for various industrial applications, including hydraulic fluids, lubricity additives for metals, metal quenching agents, compression lubricants, gear oils…

CEO: Renrong Wu
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: SHH
Employees: 718
Website: www.wellnj.com

Peers

Peers Tab

603811.SS

Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

Cap

¥3.4B

000788.SZ

PKU HealthCare Corp.,Ltd.

Cap

¥3.4B

002826.SZ

Tibet AIM Pharm. Inc.

Cap

¥3.3B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 603351.SS

What does Nanjing Well Pharmaceutical Group Co.,Ltd. do?: Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 603351.SS's market cap?: Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) has a market capitalization of approximately $3.55 billion, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does 603351.SS pay a dividend?: Yes — Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) pays a dividend annually, with a trailing-twelve-month yield of 2.29%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.